Oral ibandronate for the treatment of metastatic bone disease in breast cancer: Efficacy and safety results from a randomized, double-blind, placebo-controlled trial

Debu Tripathy, M. Lichinitzer, A. Lazarev, S. A. MacLachlan, J. Apffelstaedt, M. Budde, B. Bergstrom, E. Abdi, N. Abramson, T. M. Baker, L. W. Kirkegaard, J. R. Schmidt, D. Bell, R. Bell, R. J. Belt, J. I. Bernstein, R. G. Just, R. A. Burningham, B. Trafficante, V. CaggianoT. Cartwright, I. N. Chernozemsky, P. Clingan, P. Conkling, J. B. Craig, A. B. Grosbach, D. Decker, E. Dickman, W. Dugan, W. Dunlap, P. D. Eisenberg, J. Ellerton, M. Ettinger, F. Ey, G. Falkson, C. Falkson, K. Fink, J. Fleagle, T. Forlenza, V. A. Gorbunova, G. E. Gross, T. Grotes, J. Grygiel, A. Gudgeon, I. D. Werner, D. Hacking, G. W. Harrer, V. Harvey, R. Hirsch, A. Koletsky, J. P. Jordaan, D. Kaye Cash, R. Sh Khasanov, J. A. LaFata, S. LaFollette, P. Koshla, G. Landers, H. C. Lebos, J. Lloyd Wade, T. Lowenthal, R. Lyons, S. A. McLachlan, R. Murray, D. Perez, K. Phadke, B. Rapoport, P. G. Rausch, B. Robinson, G. Sarna, A. Saven, M. Schwartz, V. F. Semiglazov, J. Stewart, K. Sunderland, L. Thomas, C. L. Vogel, M. Martinez-Rio, D. A. Vorobiof, S. Wilks, P. Woolley

Research output: Contribution to journalArticlepeer-review

74 Scopus citations

Fingerprint Dive into the research topics of 'Oral ibandronate for the treatment of metastatic bone disease in breast cancer: Efficacy and safety results from a randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences